| 1 |
30935402 |
10.1186/s13045-019-0716-7 |
2020 |
Molecular pathogenic pathways in extranodal NK/T cell lymphoma. |
PTPRK |
| 2 |
29966370 |
10.3390/ijms19071931 |
2018 |
The Genomics and Molecular Biology of Natural Killer/T-Cell Lymphoma: Opportunities for Translation. |
PTPRK |
| 3 |
26432421 |
10.1002/cam4.551 |
2016 |
Whole-exome sequencing of breast cancer, malignant peripheral nerve sheath tumor and neurofibroma from a patient with neurofibromatosis type 1. |
PTPRK |
| 4 |
25612622 |
10.1182/blood-2014-07-588970 |
2015 |
Receptor-type tyrosine-protein phosphatase κ directly targets STAT3 activation for tumor suppression in nasal NK/T-cell lymphoma. |
PTPRK |
| 5 |
24045499 |
10.1038/leu.2013.270 |
2014 |
DNA methylation of membrane-bound tyrosine phosphatase genes in acute lymphoblastic leukaemia. |
PTPRK |
| 6 |
24612100 |
10.1111/cas.12388 |
2014 |
High-resolution genomic copy number profiling of primary intraocular lymphoma by single nucleotide polymorphism microarrays. |
PTPRK |
| 7 |
17720884 |
10.1182/blood-2006-11-059881 |
2008 |
Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells. |
PTPRK |
| 8 |
18287131 |
10.3324/haematol.12251 |
2008 |
Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas. |
PTPRK |
| 9 |
18645192 |
10.1200/JCO.2008.16.1455 |
2008 |
Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course. |
PTPRK |
| 10 |
12591717 |
|
2003 |
Novel tumor suppressor loci on 6q22-23 in primary central nervous system lymphomas. |
PTPRK |
Datasets
Models
